(Q51092485)

29 March 2018

title

Naloxone-induced changes in tachykinin NK3 receptor modulation of experimental anxiety in mice. (English)

1 reference

29 March 2018

0 references

Ribeiro SJ

1

1 reference

29 March 2018

De Lima TC

series ordinal

2

1 reference

29 March 2018

language of work or name

English

0 references

publication date

1 December 1998

1 reference

29 March 2018

number of pages

4

1 reference

inferred from page(s)

published in

Neuroscience Letters

1 reference

29 March 2018

volume

258

1 reference

29 March 2018

page(s)

155-158

1 reference

29 March 2018

issue

3

1 reference

29 March 2018

Naloxone blocks the antianxiety but not the motor effects of benzodiazepines and pentobarbital: experimental studies and literature review

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900880-5

7 January 2021

Naloxone potentiates the effects of subeffective doses of anxiolytic agents in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900880-5

7 January 2021

Functional characterization by heterologous expression of a novel cloned tachykinin peptide receptor.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900880-5

7 January 2021

A note on a simple apparatus for detecting neurological deficit in rats and mice

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900880-5

7 January 2021

Anxiolytic action of a neurokinin1 receptor antagonist in the social interaction test.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900880-5

7 January 2021

Multivariate assessment of locomotor behavior: pharmacological and behavioral analyses

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900880-5

7 January 2021

CCK in animal and human research on anxiety

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900880-5

7 January 2021

Diversity in mammalian tachykinin peptidergic neurons: multiple peptides, receptors, and regulatory mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900880-5

7 January 2021

A review of the validity and variability of the elevated plus-maze as an animal model of anxiety

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900880-5

7 January 2021

Intracerebroventricular injections in mice. Some methodological refinements

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900880-5

7 January 2021

Chronic infusion of a CRH1 receptor antisense oligodeoxynucleotide into the central nucleus of the amygdala reduced anxiety-related behavior in socially defeated rats

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900880-5

7 January 2021

The use of a plus-maze to measure anxiety in the mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900880-5

7 January 2021

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900880-5

1 reference

7 January 2021

Tachykinin-induced changes in beta-endorphin gene expression in the rat arcuate nucleus.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900880-5

7 January 2021

Opioid-receptor mRNA expression in the rat CNS: anatomical and functional implications

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900880-5

7 January 2021

Effects of microinjections of mu and kappa receptor agonists into the dorsal periaqueductal gray of rats submitted to the plus maze test.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900880-5

7 January 2021

Mammalian Tachykinin Receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900880-5

7 January 2021

The neuroanatomical basis of anxiety

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900880-5

7 January 2021

Kappa opioid agonists produce anxiolytic-like behavior on the elevated plus-maze

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900880-5

7 January 2021

Tachykinin NK(3)receptor involvement in anxiety.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900880-5

7 January 2021

Distribution of messenger RNAs encoding enkephalin, substance P, somatostatin, galanin, vasoactive intestinal polypeptide, neuropeptide Y, and calcitonin gene-related peptide in the midbrain periaqueductal grey in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900880-5

7 January 2021

Anxiolytic activity of tachykinin NK2 receptor antagonists in the mouse light-dark box.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900880-5

7 January 2021

Central and peripheral administration of atriopeptin is anxiolytic in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900880-5

7 January 2021

Effects of central administration of tachykinin receptor agonists and antagonists on plus-maze behavior in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900880-5

7 January 2021

Involvement of the opioid system in the anxiolytic effect of diazepam in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900880-5

7 January 2021

The anxiolytic-like activity of GR159897, a non-peptide NK2 receptor antagonist, in rodent and primate models of anxiety

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900880-5

7 January 2021

Central nervous system pharmacology of neuropeptide Y.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900880-5

7 January 2021

Localization of Fos-like immunoreactivity induced by the NK3 tachykinin receptor agonist, senktide, in the guinea-pig brain

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900880-5

7 January 2021

Different behavioral profiles of the non-peptide substance P (NK1) antagonists CP-96,345 and RP 67580 in Swiss albino mice in the black-and-white box.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900880-5

7 January 2021

10.1016/S0304-3940(98)00880-5

Identifiers

DOI

1 reference

29 March 2018

PubMed ID

9885954

1 reference

29 March 2018